In this study, we used the SP142 rabbit monoclonal antibody that recognizes an epitope in the C-terminus of human PD-L1 protein and an empirically selected cutpoint that corresponds to the upper quartile of expression levels in the cohort to determine PD-L1 tumor cell expression status and its relation to outcome in breast cancer subsets. The gene discussed is CD274; the disease is neoplasm.